-
EP4087926
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4087926
| EP4087926 - NUCLEIC ACID AND CELL PRESERVATIVE COMPOSITIONS AND METHODS OF USE [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 11.10.2024 Database last updated on 04.11.2024 | |
| Former | Examination is in progress Status updated on 23.02.2024 | ||
| Former | Request for examination was made Status updated on 14.10.2022 | ||
| Former | The international publication has been made Status updated on 16.07.2021 | ||
| Former | unknown Status updated on 12.02.2021 | Most recent event Tooltip | 11.10.2024 | Application deemed to be withdrawn | published on 13.11.2024 [2024/46] | Applicant(s) | For all designated states SiO2 Medical Products, Inc. 2250 Riley Street Auburn, AL 36832 / US | [2022/46] | Inventor(s) | 01 /
PICCIRILLI, Joseph 1408 South Plymouth Court Chicago, Illinois 60605 / US | 02 /
WEIKART, Christopher c/o SiO2 Medical Products, Inc. 2250 Riley Street Auburn, Alabama 36832 / US | 03 /
KLIBANOV, Alexander M. c/o SiO2 Medical Products, Inc. 2250 Riley Street Auburn, Alabama 36832 / US | [2022/46] | Representative(s) | Maiwald GmbH Engineering Elisenhof Elisenstrasse 3 80335 München / DE | [N/P] |
| Former [2022/46] | Maiwald Patent- und Rechtsanwaltsgesellschaft mbH Engineering Elisenhof Elisenstrasse 3 80335 München / DE | Application number, filing date | 21703341.4 | 08.01.2021 | [2022/46] | WO2021US12844 | Priority number, date | US202062959818P | 10.01.2020 Original published format: US 202062959818 P | US202063011468P | 17.04.2020 Original published format: US 202063011468 P | [2022/46] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021142375 | Date: | 15.07.2021 | Language: | EN | [2021/28] | Type: | A1 Application with search report | No.: | EP4087926 | Date: | 16.11.2022 | Language: | EN | The application published by WIPO in one of the EPO official languages on 15.07.2021 takes the place of the publication of the European patent application. | [2022/46] | Search report(s) | International search report - published on: | EP | 15.07.2021 | Classification | IPC: | C12N15/10 | [2022/46] | CPC: |
C12N15/1003 (EP,US);
C12Q1/6806 (US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/46] | Title | German: | NUKLEINSÄURE- UND ZELLKONSERVIERENDE ZUSAMMENSETZUNGEN UND VERFAHREN ZUR VERWENDUNG | [2022/46] | English: | NUCLEIC ACID AND CELL PRESERVATIVE COMPOSITIONS AND METHODS OF USE | [2022/46] | French: | COMPOSITIONS DE CONSERVATION D'ACIDES NUCLÉIQUES ET DE CELLULES ET PROCÉDÉS D'UTILISATION | [2022/46] | Entry into regional phase | 29.07.2022 | National basic fee paid | 29.07.2022 | Designation fee(s) paid | 29.07.2022 | Examination fee paid | Examination procedure | 29.07.2022 | Examination requested [2022/46] | 29.07.2022 | Date on which the examining division has become responsible | 22.03.2023 | Despatch of communication of loss of particular rights: Claims {1} | 27.03.2023 | Amendment by applicant (claims and/or description) | 27.02.2024 | Despatch of a communication from the examining division (Time limit: M04) | 28.06.2024 | Application deemed to be withdrawn, date of legal effect [2024/46] | 18.07.2024 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2024/46] | Request for further processing for: | Loss of rights: Claims | 27.03.2023 | Request for further processing filed | 27.03.2023 | Full payment received (date of receipt of payment) Request granted | 04.04.2023 | Decision despatched | 27.03.2023 | Request for further processing filed | 27.03.2023 | Full payment received (date of receipt of payment) Request granted | 04.04.2023 | Decision despatched | Fees paid | Renewal fee | 27.01.2023 | Renewal fee patent year 03 | 29.01.2024 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]US2003113705 (MCMILLIAN RAY A [US]) [Y] 1-55 * the whole document *; | [XI]WO2013148346 (LONGHORN VACCINES & DIAGNOSTICS LLC [US]) [X] 1-4,7-55 * pages 11,12 * [I] 5,6; | [Y]CN105158455 (SHENZHEN NAKE BIOLOGY CO LTD) [Y] 1-55 * the whole document *; | [XI] - Shankar Sidharth ET AL, "A low-cost and easy-to-use cell preservation reagent for 4°C or room temperature sample storage", bioRxiv, doi:10.1101/745232, (20190823), URL: https://www.biorxiv.org/content/10.1101/745232v1.full, (20210319), XP055787621 [X] 1 * the whole document * [I] 2-55 DOI: http://dx.doi.org/10.1101/745232 | [Y] - MIAO ZHANG ET AL, "Freeze-drying of mammalian cells using trehalose: preservation of DNA integrity", SCIENTIFIC REPORTS, (20170724), vol. 7, no. 1, doi:10.1038/s41598-017-06542-z, XP055751762 [Y] 1-55 * the whole document * DOI: http://dx.doi.org/10.1038/s41598-017-06542-z | [XP] - Organick Lee ET AL, "A comprehensive study of synthetic DNA preservation for DNA data storage", bioRxiv, doi:10.1101/2020.09.19.304014, (20200930), URL: https://www.biorxiv.org/content/10.1101/2020.09.19.304014v1.full.pdf, (20210406), XP055792520 [XP] 1-55 * the whole document * DOI: http://dx.doi.org/10.1101/2020.09.19.304014 | by applicant | - BETAGERI, G.V.KADAJJI, V.G., Polymers, (20110000), vol. 3, pages 1972 - 2009 |